Nomura Asset Management Portfolio holdings
AUM
$36.5B
This Quarter Return
+13.28%
1 Year Return
+24.64%
3 Year Return
+107.53%
5 Year Return
+178.5%
10 Year Return
+465.21%
AUM
$14.9B
AUM Growth
+$14.9B
(+14%)
Cap. Flow
+$517M
Cap. Flow
% of AUM
3.48%
Top 10 Holdings %
Top 10 Hldgs %
22.17%
Holding
1,355
New
47
Increased
595
Reduced
228
Closed
35
Top Buys
| 1 |
Starbucks
SBUX
|
$64.4M |
| 2 |
Walt Disney
DIS
|
$63.5M |
| 3 |
JPMorgan Chase
JPM
|
$59.2M |
| 4 |
Honeywell
HON
|
$35.4M |
| 5 |
Medtronic
MDT
|
$35.2M |
Top Sells
| 1 |
Salesforce
CRM
|
$69.3M |
| 2 |
Atlassian
TEAM
|
$43.7M |
| 3 |
Amazon
AMZN
|
$40.3M |
| 4 |
Adobe
ADBE
|
$38.5M |
| 5 |
Zoom
ZM
|
$36M |
Sector Composition
| 1 | Technology | 23.71% |
| 2 | Healthcare | 14.42% |
| 3 | Consumer Discretionary | 13.25% |
| 4 | Financials | 10.58% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Brown-Forman Class A
BF.A
$13.5B
| – | – |
0
| – | – |
|
1327
Bausch Health
BHC
$2.72B
| – | – |
0
| – | – |
|
1328
BHP
BHP
$142B
| – | – |
0
| – | – |
|
1329
BlackLine
BL
$3.26B
| – | – |
0
| – | – |
|
|
BLUE
1330
DELISTED
bluebird bio
BLUE
| – | – |
0
| – | – |
|
1331
Bank of Montreal
BMO
$88.5B
| – | – |
0
| – | – |
|
1332
Brookfield
BN
$97.7B
| – | – |
0
| – | – |
|
1333
Scotiabank
BNS
$78.1B
| – | – |
-5,742
| Closed | -$238K |
|
1334
BP
BP
$88.8B
| – | – |
0
| – | – |
|
|
BPMC
1335
DELISTED
Blueprint Medicines
BPMC
| – | – |
0
| – | – |
|
1336
Bruker
BRKR
$4.45B
| – | – |
0
| – | – |
|
1337
B2Gold
BTG
$5.45B
| – | – |
0
| – | – |
|
1338
British American Tobacco
BTI
$120B
| – | – |
0
| – | – |
|
1339
BWX Technologies
BWXT
$14.7B
| – | – |
0
| – | – |
|
1340
Boyd Gaming
BYD
$6.84B
| – | – |
0
| – | – |
|
1341
Beyond Meat
BYND
$178M
| – | – |
0
| – | – |
|
1342
Dolby
DLB
$6.94B
| – | – |
0
| – | – |
|
|
BBBY
1343
Bed Bath & Beyond, Inc.
BBBY
$491M
| – | – |
0
| – | – |
|
|
BZUN
1344
Baozun
BZUN
$233M
| – | – |
-7,100
| Closed | -$231K |
|
1345
Credit Acceptance
CACC
$5.84B
| – | – |
0
| – | – |
|
1346
CAE Inc
CAE
$8.55B
| – | – |
0
| – | – |
|
1347
Cytokinetics
CYTK
$5.98B
| – | – |
0
| – | – |
|